Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,319,000 | 7,994,000 | 22,998,000 | 19,898,000 | 2,894,000 |
| Marketable Securities | 2,815,000 | N/A | N/A | N/A | 14,555,000 |
| Receivables | 9,873,000 | 10,391,000 | 7,798,000 | 7,773,000 | 8,310,000 |
| Inventories | 6,093,000 | 6,756,000 | 5,540,000 | 5,658,000 | 5,830,000 |
| Other current assets | 2,585,000 | 2,575,000 | 2,331,000 | 2,471,000 | 2,102,000 |
| TOTAL | $26,685,000 | $27,716,000 | $38,667,000 | $35,800,000 | $33,691,000 |
| Non-Current Assets | |||||
| PPE Net | 15,840,000 | 15,904,000 | 13,165,000 | 13,577,000 | 14,075,000 |
| Investments And Advances | 10,225,000 | 0 | 0 | 0 | 20,426,000 |
| Intangibles | 64,923,000 | 65,176,000 | 21,539,000 | 21,571,000 | 22,370,000 |
| Other Non-Current Assets | 5,645,000 | 15,832,000 | 23,553,000 | 24,847,000 | 4,943,000 |
| TOTAL | $96,633,000 | $96,912,000 | $58,257,000 | $59,995,000 | $61,814,000 |
| Total Assets | $123,318,000 | $124,628,000 | $96,924,000 | $95,795,000 | $95,505,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,627,000 | 12,631,000 | 5,408,000 | 4,484,000 | 5,313,000 |
| Accounts payable and accrued liabilities | 4,788,000 | 3,987,000 | 3,509,000 | 3,561,000 | 4,012,000 |
| Other current liabilities | 9,533,000 | 11,039,000 | 8,912,000 | 9,387,000 | 8,329,000 |
| TOTAL | $24,658,000 | $27,657,000 | $17,829,000 | $17,432,000 | $19,470,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,360,000 | 14,331,000 | 13,235,000 | 13,445,000 | 8,675,000 |
| Other Non-Current Liabilities | 6,746,000 | 16,378,000 | 10,024,000 | 9,687,000 | 5,473,000 |
| TOTAL | $28,891,000 | $30,753,000 | $23,279,000 | $23,147,000 | $18,573,000 |
| Total Liabilities | $53,549,000 | $58,410,000 | $41,108,000 | $40,579,000 | $38,043,000 |
| Shareholders' Equity | |||||
| Common Shares | 957,000 | N/A | N/A | N/A | 957,000 |
| Retained earnings | 62,364,000 | N/A | N/A | N/A | 56,562,000 |
| Other shareholders' equity | 6,573,000 | 66,218,000 | 55,816,000 | 55,216,000 | 75,000 |
| TOTAL | $69,769,000 | $66,218,000 | $55,816,000 | $55,216,000 | $57,462,000 |
| Total Liabilities And Equity | $123,318,000 | $124,628,000 | $96,924,000 | $95,795,000 | $95,505,000 |